Money and Finance
I've been meaning to revisit my analysis on Johnson and Johnson since it's been a year since I first looked at them. I've learned so much more about stock analysis in that time so this will be more thorough and hopefully more insightful. They are a dividend champion with 50 consecutive years of increasing dividends. J&J closed trading on Wednesday, April 3rd at $82.07.
Company Background (sourced from Yahoo! Finance):
Johnson & Johnson, together with its subsidiaries, engages in the research and development, manufacture, and sale of various products in the health care field worldwide. The company operates in three segments: Consumer, Pharmaceutical, and Medical Devices and Diagnostics. The Consumer segment offers products used in the baby care, skin care, oral care, wound care, and womens health fields, as well as nutritional and over-the-counter pharmaceutical products, and wellness and prevention platforms under the JOHNSONS, AVEENO, CLEAN & CLEAR, NEUTROGENA, RoC, LUBRIDERM, DABAO, VENDÔME, LISTERINE, REMBRANDT, REACH, BAND-AID, NEOSPORIN, CAREFREE, STAYFREE, SPLENDA, TYLENOL, SUDAFED, ZYRTEC, MOTRIN IB, and PEPCID AC brand names. This segment markets its products to the general public, as well as to retail outlets and distributors. The Pharmaceutical segment provides various products in the areas of anti-infective, antipsychotic, contraceptive, gastrointestinal, hematology, immunology, infectious diseases, neurology, oncology, pain management, thrombosis, and vaccines. This segment distributes its products directly to retailers, wholesalers, and health care professionals for prescription use. The Medical Devices and Diagnostics segment offers products to treat cardiovascular disease; orthopaedic and neurological products; blood glucose monitoring and insulin delivery products; general surgery, biosurgical, and energy products; professional diagnostic products; infection prevention products; and disposable contact lenses. This segment distributes its products directly, as well as through surgical supply and other distributors to wholesalers, hospitals, and retailers.
Read more »
- 3m (mmm) Dividend Stock Analysis
The Board of Directors at 3M Company (MMM) announced a 35% increase in the dividend last week which is amazing for a company that already boasts a $92B market cap. I last looked at 3M almost a year ago, January 2013, and felt it was a bit overvalued...
- Colgate-palmolive Dividend Stock Analysis
I still owe a stock analysis from February, so today we'll look at Colgate-Palmolive (CL). They are a dividend champion announcing their 50th consecutive year of dividend increases last week. Colgate-Palmolive closed trading on Friday, March 8th...
- 3m Stock Analysis
It's time for another stock analysis report and this time I'll look at another dividend champion, 3M (MMM). 3M closed trading on Friday, January 11th at $96.28. Company Background: 3M Company operates as a diversified technology company worldwide....
- Becton Dickinson Stock Analysis
Since I'm really lacking on health care industry exposure it was time to start looking at some of the different companies, so today we'll look at Becton Dickinson and Company. Becton Dickinson closed trading on Monday, November 5th at $76.59....
- A Closer Look At Johnson & Johnson (jnj)
As a stock holder of many different companies I find myself checking through all kinds news and analysis on the internet. This week I thought I'd share a couple of items about the Dividend Aristocrat Johnson & Johnson. Some fellow dividend bloggers...
Money and Finance
Johnson and Johnson Dividend Stock Analysis
I've been meaning to revisit my analysis on Johnson and Johnson since it's been a year since I first looked at them. I've learned so much more about stock analysis in that time so this will be more thorough and hopefully more insightful. They are a dividend champion with 50 consecutive years of increasing dividends. J&J closed trading on Wednesday, April 3rd at $82.07.
Company Background (sourced from Yahoo! Finance):
Johnson & Johnson, together with its subsidiaries, engages in the research and development, manufacture, and sale of various products in the health care field worldwide. The company operates in three segments: Consumer, Pharmaceutical, and Medical Devices and Diagnostics. The Consumer segment offers products used in the baby care, skin care, oral care, wound care, and womens health fields, as well as nutritional and over-the-counter pharmaceutical products, and wellness and prevention platforms under the JOHNSONS, AVEENO, CLEAN & CLEAR, NEUTROGENA, RoC, LUBRIDERM, DABAO, VENDÔME, LISTERINE, REMBRANDT, REACH, BAND-AID, NEOSPORIN, CAREFREE, STAYFREE, SPLENDA, TYLENOL, SUDAFED, ZYRTEC, MOTRIN IB, and PEPCID AC brand names. This segment markets its products to the general public, as well as to retail outlets and distributors. The Pharmaceutical segment provides various products in the areas of anti-infective, antipsychotic, contraceptive, gastrointestinal, hematology, immunology, infectious diseases, neurology, oncology, pain management, thrombosis, and vaccines. This segment distributes its products directly to retailers, wholesalers, and health care professionals for prescription use. The Medical Devices and Diagnostics segment offers products to treat cardiovascular disease; orthopaedic and neurological products; blood glucose monitoring and insulin delivery products; general surgery, biosurgical, and energy products; professional diagnostic products; infection prevention products; and disposable contact lenses. This segment distributes its products directly, as well as through surgical supply and other distributors to wholesalers, hospitals, and retailers.
Read more »
- 3m (mmm) Dividend Stock Analysis
The Board of Directors at 3M Company (MMM) announced a 35% increase in the dividend last week which is amazing for a company that already boasts a $92B market cap. I last looked at 3M almost a year ago, January 2013, and felt it was a bit overvalued...
- Colgate-palmolive Dividend Stock Analysis
I still owe a stock analysis from February, so today we'll look at Colgate-Palmolive (CL). They are a dividend champion announcing their 50th consecutive year of dividend increases last week. Colgate-Palmolive closed trading on Friday, March 8th...
- 3m Stock Analysis
It's time for another stock analysis report and this time I'll look at another dividend champion, 3M (MMM). 3M closed trading on Friday, January 11th at $96.28. Company Background: 3M Company operates as a diversified technology company worldwide....
- Becton Dickinson Stock Analysis
Since I'm really lacking on health care industry exposure it was time to start looking at some of the different companies, so today we'll look at Becton Dickinson and Company. Becton Dickinson closed trading on Monday, November 5th at $76.59....
- A Closer Look At Johnson & Johnson (jnj)
As a stock holder of many different companies I find myself checking through all kinds news and analysis on the internet. This week I thought I'd share a couple of items about the Dividend Aristocrat Johnson & Johnson. Some fellow dividend bloggers...